Are colonoscopies dangerous?
Colorectal cancer screening is an important part of staying well. Colonoscopies are a proven, effective, and safe way to screen, prevent, and detect colorectal cancer early. They give you the best odds for a long, healthy, and productive life.
Are there risks?
While there are risks associated with even the most routine medical procedures, the benefits of a colonoscopy significantly outweigh the associated risks for people ages 45 to 75.
The American Society for Gastrointestinal Endoscopy estimates that only three in 1,000 colonoscopies lead to serious complications.
Possible complications
While colonoscopy complications that lead to death are exceptionally rare, there are more common complications that may result in temporary discomfort or require further medical care.
Risk for older adults
People over age 75 are at higher risk for complications from colonoscopies due to:
- Underlying health issues
- Dehydration or electrolyte imbalance from prep for the procedure
Those over age 75 should discuss all the benefits and risks of the procedure with their doctor.
Risks vs. benefits
Research indicates that skipping or delaying colonoscopies is significantly more dangerous to your long-term health than having the actual procedure.
In other words, a person’s risk of developing colorectal cancer is higher than the risk of having a complication from a colonoscopy.
Life-saving colonoscopy information
A colonoscopy is considered the gold standard in colorectal cancer screening. Explore our resources to prepare for your upcoming colonoscopy.
Screening for others
Ten ways to encourage loved ones to get screenedTop resources
Dak Prescott joins Alliance to ‘LEAD FROM BEHIND’
Initiative aims to reduce stigma and educate about screening choices, as the Colorectal Cancer Alliance launches a health equity fund to decrease disparities.
Act now to create a coverage pathway for future blood-based detection
On the horizon are blood tests that have shown the ability to detect a variety of cancers including colorectal and rare cancers. Though these tests are still in development and are not yet approved by the FDA, clinical trials have shown impressive results.
John and Mary: parents honor son who died from CRC by talking screening & stigma
In February of 2022, John and Mary experienced the unimaginable. Their 36-year-old son, Jonathan, died of stage IV colon cancer. Though Jonathan had been dealing with ulcerative colitis from the time he was twelve, no one would have predicted this outcome twenty-four years later.